April 25, 2019
Rose
The research done to create the life-saving pill was funded by taxpayer money, but talks have stalled about royalties so the government hasn't been able to collect. For its part, a Gilead spokesman said “there are no ongoing negotiations between Gilead and HHS” about patents owned by the government. In other pharmaceutical news: the fault lines in the Democratic party over drug prices; experts suggest its time to kill off copays; FDA taps a public health expert to lead its regulatory policy office; the FTC sues Surescripts; and more.
from Kaiser Health News http://bit.ly/2IXcKps
April 25, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Oklahoma Is Latest State To Signal Interest In Adding Medicaid Work Requirements- State Highlights: Aid-In-Dying Bill Moves To Senate In Hawaii; Despite High Rate Of HIV Diagnoses in Ga., Preventive Drug Regimen Is Low
- Longer Looks: Mental Illness And Homelessness; Death By Bacon; The End Of Mall-Walkers
- Viewpoints: Changes To ACA, Medicaid Could Wipe Out Progress On HIV; Opioid Summit Missed Mark On Best Way To Respond To Epidemic
- Mississippi Poised To Pass 15-Week Abortion Ban That Would Challenge Supreme Court Ruling
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment